BigHat Bio
Noelle Mullin currently serves as Associate Director of Discovery and Translational Medicine at BigHat Biosciences, focusing on therapeutic antibody programs in oncology and inflammatory diseases. Prior experience includes roles as Principal Scientist at Pfizer, where leadership of drug discovery programs emphasized immune-oncology and inflammatory disease, and Senior Scientist, leading immune-oncology initiatives. Noelle co-founded Prellis Biologics, which aims to develop advanced technologies for creating viable human tissues. A Postdoctoral Fellow at Stanford University, research revolved around tumor evolution mechanisms in targeted therapies, and earlier work as a Graduate Student at UC San Francisco emphasized synthetically lethal strategies in cancer research. Noelle holds a PhD in Biomedical Sciences with a focus on Hematology Oncology from UC San Francisco and a BA in Molecular, Cellular, and Developmental Biology from UC Santa Barbara.
This person is not in any teams
This person is not in any offices
BigHat Bio
1 followers
BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.